Research and Markets has announced the addition of the "IMS Pharmaceutical Pricing & Reimbursement Concise Guide: Russia" report to their offering.
The Pharmaceutical Pricing & Reimbursement Concise Guides are established as the definitive reference and training text for P&R professionals around the world, drawing on the long-standing expertise of pricing and reimbursement specialists to provide industry players and decision makers with a thorough understanding of the rules and regulations governing P&R in international markets.
This report covers key developments in P&R, market access, cost containment, trade margins and healthcare issues.
Key Topics Covered:
1. HEALTHCARE SYSTEM
Facts & Figures
Provision & Funding
New Priorities to 2025
Amendments to Drug Law
Concerns about Withdrawal of Cheap Essential Drugs
Further Amendments to Pricing Methodology
Admission to Reimbursement
Other Public Schemes
Proposals for Further Amendments to Procedure
Plans for a Comprehensive National Reimbursement Scheme
Coverage of Rare Diseases
5. PRICE BUILD UP
6. COST CONTAINMENT
7. FUTURE DEVELOPMENTS
Plans for Roll-out of Drug Reimbursement System
Further Amendment to EDL, DLO Procedures
Further Amendments to Pricing Regulations
8. NAMES & ADDRESSES
For more information about this report visit http://www.researchandmarkets.com/research/jthppm/ims
View source version on businesswire.com: http://www.businesswire.com/news/home/20161005006092/en/Business Wire
Last updated on: 05/10/2016
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.